OP Bio Factory Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
OP Bio Factory Co., Ltd. - overview
Established
2006
Location
Uruma-shi, Okinawa, Japan
Primary Industry
Biotechnology
About
Based in Japan, OP Bio Factory Co. , Ltd. specializes in sustainable marine biological resource utilization, focusing on microalgae for various applications in pharmaceuticals, food, cosmetics, and environmental technologies. Founded in 2006, OP Bio Factory Co.
, Ltd. is located in Uruma-shi, Japan. The company focuses on the sustainable use of marine resources, particularly microalgae. OP Bio Factory has engaged in strategic shifts to enhance its operational focus on microalgae-based products and solutions.
The company operates independently without any parent or subsidiary associations. The founder's prior history is not documented in available sources. OP Bio Factory Co. , Ltd.
specializes in the sustainable utilization of marine biological resources, offering a range of products and services primarily centered around microalgae. Their core offerings include the collection and research of marine macro and micro-organisms, particularly focusing on microalgae such as Pavlova sp. The company operates as a distributor for Varicon Aqua's photobioreactors, facilitating their installation and integration into various applications. OP Bio Factory's services extend to the exploration of new compounds and functionalities for use in pharmaceuticals, food, cosmetics, and environmental technologies.
The firm primarily serves clients in the pharmaceutical, food, cosmetic, and agricultural sectors, providing tailored solutions and custom assay systems based on specific customer requirements. Their products and services reach markets in Japan, the United States, and various regions in Europe, emphasizing the global nature of their operations. The revenue model for OP Bio Factory comprises various structures, including partnerships and direct sales to clients in B2B transactions. The company engages in sales of photobioreactors and provides research and development services on a project basis, typically outlined through formal agreements.
Their flagship products, such as the Pavlova MCT+ supplement, are marketed directly to consumers and businesses alike, with pricing structures set according to the scale and scope of each project or product. The company also offers screening services and commercial production processes, allowing for a diversified revenue stream that adapts to the unique needs of their clientele. This multifaceted approach positions OP Bio Factory to cater to a broad market while maintaining consistent engagement with both individual and corporate customers.
Current Investors
Rohto Pharmaceutical
Primary Industry
Biotechnology
Sub Industries
Health Foods & Nutritional Supplements, Bioinformatics, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.opbio.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
OP Bio Factory Co., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LP Direct | Completed | OP Bio Factory Co., Ltd. | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.